Juul Labs has received authorization from the U.S. Food and Drug Administration (FDA) to continue selling its e-cigarettes and refill cartridges in tobacco and menthol flavors in the United States. This approval marks a reversal of a 2022 FDA ban that halted Juul's sales amid concerns over the health effects of its products. The decision follows a five-year regulatory review and comes after Juul faced significant challenges, including a federal sales ban and a class action lawsuit. The FDA deemed Juul's authorized products "appropriate for the protection of public health," allowing the company to market its e-cigarettes as an alternative for adult smokers. The authorization ends a period of regulatory uncertainty and permits Juul to maintain its presence in the U.S. vaping market.